Informed consent form authoring, explained.

Informed consent explained: the document a volunteer reads before saying yes

One psoriasis study, from the changed protocol to a second signature

1. The protocol changesSeptember 28, 2026: VLT-302's Amendment 3 adds liver tests and a longer follow-up, and the brochure adds a new liver risk.
2. The master form is rewrittenEvery changed fact is traced to its page, written in plain words and signed by a writer, a doctor and a lawyer.
3. The change reaches every formEleven country, site and special forms take the same change, and only that change, then translation.
4. Each board approvesA US central institutional review board (IRB), national ethics committees and a Canadian research ethics board each review their own package, from October 21 on.
5. Sites use it, people re-consentOnly after approval. A participant in the study signs the new form at their next visit, if the board or sponsor decides they should.

Steps 2 and 3 are the subject of this guide. The study, people and figures in this example are fictional.

A reading grade no law names, a sentence you may not simplify, and two more surprises

Four consent terms: master form, Investigator's Brochure, IRB, re-consent

Fourteen terms are defined in the one-page summary.

One master ICF, many country ICFs: the family of consent forms behind a global trial

In shortOne study has one protocol and a whole set of consent forms. Each form shares most of its sentences with the master, adds some of its own, and has its own version number, reading grade, board and date. Keeping the family in step is most of the work after the first draft.

Which special forms a study needs depends on the study; ICH E6(R3), the international good clinical practice guideline, covers assent in section 2.8.12.10 The rows are this guide's summary of common practice.

The consent rules as of November 2026: what is law, what is proposed and what is new

In shortFour rule books shape most forms: FDA's 21 CFR part 50 for FDA-regulated studies, the Common Rule at 45 CFR 46 for federally supported research, the EU Clinical Trials Regulation, and ICH E6(R3), the international good clinical practice guideline. Some of what people treat as settled is still a proposal: FDA has not finalized key information. A UK reform arrived in April 2026, and EU guidance keeps moving.

FDA says it intends to use enforcement discretion, holding back from enforcing, for studies already under way when the proposed requirements would take effect.11

The required elements of informed consent, side by side across 21 CFR 50.25, the Common Rule, EU Article 29 and ICH

In shortFDA lists eight basic and six additional elements plus one exact statement. The Common Rule lists nine and nine. ICH E6(R3) lists 22 items. EU Article 29 sets out what a person must understand, then names the compensation system and the EU trial number. No single list covers a global form, so teams build a checklist that combines them.

Four things a checklist of elements misses

The ClinicalTrials.gov statement, which goes in word for word

For an applicable clinical trial, 21 CFR 50.25(c) says the statement "shall be provided" in consent documents and processes, and prints it:1

A plain language edit would change "Web site" and the old web address, so any process that rewrites sentences needs a way to lock this passage and any others your counsel names. The passage also raises the form's reading grade slightly, so mark it as required wording when you explain your score.

What belongs in the key information section of a consent form, and how long it should be

In shortThe Common Rule requires consent to open with "a concise and focused presentation of the key information" that helps a person see why they might or might not take part. The 2024 draft guidance suggests "generally no more than a few pages". It works as a filter on what goes first, and most required elements still belong further back.

The draft is explicit that this is one approach. A short, simple form may itself be the key information: "it does not need to be labeled 'key information.'"11

Informed consent reading level: how grades are worked out, and why nine in ten forms miss grade 8

In shortA reading grade estimates the US school grade a reader needs, and grade 8 is a convention set by review boards. A 2024 study of 5,239 US trial forms found a mean Flesch-Kincaid grade of 10.99, with 91% above grade 8. That formula counts sentence length and syllables, and meaning plays no part. A common cause of high scores is sentences lifted from sources written for doctors.

Flesch-Kincaid worked through on three consent sentences

The published formula is: grade = 0.39 × words per sentence + 11.8 × syllables per word − 15.59.5 Here it is by hand on three sentences from the guide's example.

Our hand count on fictional sentences. Software counts syllables and sentence breaks its own way, so a tool can differ from this by a grade or more. Fix one tool, and what it counts, for a whole study. The third sentence scores 2.3 and means nothing to someone who has never heard of a control arm.

Seven habits that lift a consent form's reading grade, and their plain language versions

Our examples. Any rewrite keeps every number and names the organ: "changes in liver tests" keeps the information, while "some blood test changes" loses it.

A low reading grade is no proof of understanding: what participants take in

In shortIn pooled studies, about half of participants understood placebo (a dummy treatment) and randomization (assignment by chance), the two ideas that separate research from care. That share had not risen over 30 years. A longer discussion and a better form have the strongest evidence. In the EU, the interview must check that the person has understood.

Turning brochure percentages into "about N in 100" without changing what the risk means

In shortA Cochrane review found natural frequencies such as "2 out of 100" are probably better understood than probabilities such as "2%". But rounding to whole people can change a comparison, and words like "rare" can hide the number. A writer should keep the drug and placebo figures together, round with a rule and let a doctor sign the result.

An Investigator's Brochure reports side effects as percentages against placebo. A Cochrane review, a formal summary of the evidence, covered 35 studies and found natural frequencies were better understood than probabilities (standardized mean difference, a measure of the size of the gain, 0.69; moderate overall quality).25 So many teams turn "11.2%" into "about 11 in 100 people". Here is the same conversion on the example study's figures, with a catch on the last three rows.

What a protocol amendment sets off: every consent form, each board and a re-consent decision

In short76% of protocols have at least one amendment, the mean is 3.3 per protocol, and an amendment takes about 260 days from need to last approval. Sites work to different protocol versions for a mean of 215 days. The master must be released before country forms can start. A revised form may not be used until its own board approves it, and someone must decide who signs again.

Who signs again? The re-consent decision under E6(R3) and FDA guidance

A changed protocol does not automatically mean everyone signs again. E6(R3) section 2.8.2 says new information that could affect willingness to continue "should be assessed to determine if re-consent is needed", asking whether it matters only to new participants or to those already in. If re-consent is needed, the new information "should be clearly identified" in the revised materials, and those need approval "in advance of use".10

FDA's guidance says revisions must be approved by the IRB "before the revisions are initiated, except when necessary to eliminate apparent immediate hazards", and that some changes may qualify for expedited review.2 In the example, the three changes land differently:

An illustration on the fictional case. The decision belongs to the medical monitor, the sponsor and the board.

The EU clock for a consent change: 38 days, then up to 31 more

The European Medicines Agency (EMA) sets the expectation after approval in its good clinical practice Q&A. A revised form should go to sites once it has the ethics committee's favorable opinion. An unjustified delay of several weeks is unacceptable, and enrolling on an outdated form that lacks important new information, or delaying re-consent, counts as noncompliance.26

Informed consent requirements by country: what the US, EU, Germany, UK and Canada each add

In shortMost of a country form is the master, translated. A short list of national rules changes the rest: who may hold the conversation, which insurer or compensation system is named, which privacy text is attached, and what language the committee reads. This list is short and easy to get wrong from memory, so teams keep it as a written rule library.

A summary for planning: your counsel should confirm a rule before it goes in a library. The UK's "named" cell reflects common practice and is not quoted from the regulations. UK simplified consent is open only where each medicine is authorized, is used as authorized in routine care, and the trial adds no medication or procedure.18

Other countries have their own rules. Japan's good clinical practice ordinance, Article 51, lists 17 items for the written information, including injury compensation and any expenses the person bears, and asks for wording as plain as possible.30

Consent form inspection findings and warning letters: wrong words, missing elements, old versions

In shortFDA lists informed consent issues among the common problems its inspectors record at clinical investigators, the people who run a trial at a site, and revised consent gets its own theme. Two 2026 warning letters turned on what a form said. A study of 64 industry forms found them long and still missing elements. EMA's findings point at version control. We found no published error rate per form.

When an FDA inspector finds a problem, FDA issues a Form 483, a written list of observations, at the end of the inspection. FDA's fiscal 2024 metrics name "inadequate subject protection; informed consent issues" among the common observations at clinical investigator inspections.31

The causes in the middle column are our reading, apart from the July 2026 letter's, which the letter describes; the letters and studies report what was found.

What a protocol amendment costs, how much of it is consent work, and what we could not find published

In shortThe Tufts Center for the Study of Drug Development (Tufts CSDD) puts the median direct cost of a substantial amendment at $141,000 in Phase II and $535,000 in Phase III. A day of delay is valued at $500,000 or $800,000 in lost sales, depending on the Tufts paper, plus $40,000 a day in direct trial cost. We found no published consent share, and no market size for consent authoring.

The lost-sales figures apply to a medicine that eventually sells, and to a delay that moves its launch. Saving a week on a consent form moves the launch only if consent was the slowest step. The direct daily cost is the safer number for most teams, and even that assumes the delay holds up the whole trial. Part C's calculator counts hours and leaves the launch value out.

Can AI write an informed consent form? What the studies and regulators say

In shortWe found nothing in the US or EU texts cited here that stops software from drafting a consent form, and a board reviews whatever reaches a participant. Two early studies show promise and also show the need for a person. The sponsor remains responsible, and E6(R3) expects systems to be fit for purpose. Annex 11, draft Annex 22 and FDA's software assurance guidance are about other work.

How consent forms are written today: medical writers, medical monitors, country managers and a redline

In shortFive or more roles pass one document among them, mostly in Word, with email as the workflow. The people are skilled; the difficulty is proving every sentence and keeping many versions in step. Teams run the work in house, through a contract research organization, or with templates and software, and many combine all three.

The medical writer, the monitor, counsel and country managers behind each form

In house, through a contract research organization, or with templates and software

VLT-302's Amendment 3: from one stale visit count to twelve updated forms and three signatures

In shortThis is the example from the top of the page, inside the product. Lena Ortiz sees which forms and sentences the amendment touches, fixes the stale visit count, accepts ten plain rewrites, adds two missing elements, signs with two colleagues, then generates tracked changes for eleven forms. Country managers accept, and people submit.

1

Twelve forms in one tree, each with its new reading grade

Lena Ortiz opens the study on Wednesday, October 7, 2026. The sources sit on the left: Protocol Amendment 3 and brochure edition 7. The master is in the middle, then 11 country, site and special forms. She replays the amendment and each form turns amber, with its sentence count, its days left and the grade it would reach if the change went in as the protocol words it. Germany goes from 10.6 to 11.3.

The new genetic research form would start at grade 12.4, the worst in the family.

2

Thirteen sentences in Germany, every board on one clock

She clicks Germany. Each changed sentence shows struck through above its new wording, with the source it rests on: P for protocol, IB for brochure, EU for the EU rule, and its own grade. Nobody has to re-read 13 pages to learn this.

Beside it, the dates run from the US central IRB on October 21 to Japan on November 6. These are the team's planned submission dates. In the EU, the legal clock starts at validation of the modification in CTIS, as section 09 explains.

3

The master is drafted from Amendment 3, the brochure and template v6.2

She asks for a draft. The software works through it in view: the protocol reader goes through 112 pages and finds 3 changes, the risk extractor finds 14 reactions and 1 new liver risk, and the consent composer writes 15 sections from the sponsor's template, key information first. Three checks follow, then the work stops at "Waiting for Lena Ortiz".

4

Statement H4 still says 12 visits; the protocol says 13

The traceability checker links 55 statements, the screens' word for sentences, and flags one. H4 says "12 visits at the study site over approximately 68 weeks". The amended Schedule of Activities, section 1.3 on page 14, marks Weeks 60 and 68 and "Total on-site visits: 13". This is the example from the top of the page.

She can apply the corrected sentence at grade 5.9, or keep the original and explain why, which sends it to the medical monitor. Release stays blocked until one of those happens.

5

Ten rewrites take the master from grade 8.5 to 6.8

The plain-language coach offers a rewrite for each hard sentence, with grades before and after: "Pharmacokinetic sampling will be performed…" at 17.8 becomes "We will take a small amount of extra blood to measure how much Veltrimab is in your body" at 7.3. By hand, with the published formula, section 06 gets 19.4 and 7.2. Syllable counters differ, and the screens' figures stand here.

She can accept, edit or keep each one. She accepts all ten, and the document reads at 6.8. A careful reviewer would still change three: "fewer than 1 in 100" drops the placebo figure of 0.7%, and "rarely" and "in rare cases" replace numbers the brochure gives (section 08).

6

Two required elements are missing, and release is blocked

The elements checker lists each rule with the statements that meet it, as chips she can open. Two rows are red: when the investigator may stop participation, under 21 CFR 50.25(b)(2), and the EU trial number. For each, it drafts one plain sentence for her to add.

Key information appears in the 50.25(c) group on this screen. In law it comes from the Common Rule and, for FDA, a proposal (section 03). She tries to sign early, and the system stops her.

7

What a participant reads first, and five questions for the conversation

The Participant tab shows the opening as a person would meet it, with the screen's estimate of about 17 minutes to read the whole form. A click writes a five-question quiz for the consent interview, each answer tied to a statement: "How many study visits will you have?" It can go to the patient panel. The result of that conversation stays with the site.

8

Three people sign, each with the meaning of the signature

With 57 of 57 statements traced, 22 of 22 elements present and the grade at 6.8, Lena signs as author: "I confirm this text matches its sources". Dr. Maya Chen signs next for medical accuracy, then Omar Haddad for privacy and legal. Only then can the country forms start. These controls support your compliance with 21 CFR Part 11 and your own quality system; your team qualifies them for your use.

9

Eleven forms take the change as tracked changes, and only that change

Amendment impact maps the three changes across every section and form. The EU trial number row touches the master and the five EU forms, and no others. Then she generates the tracked changes. Germany takes 13 and has 4 country rules checked, Japan takes 11, the pregnant partner form 5, and the genetic form is new, with 4 statements traced from section 8.9.

10

All twelve forms updated, and the country manager accepts her own

Back on the family, all 12 read "changes ready", from 6.7 to 6.9, where Germany would have reached 11.3. Priya Ranvelle opens her German form, sees the insurer sentence kept and only the master's changes tracked, and accepts with her own signature. A person sends each package. The software never submits.

The solution's design targets are 7 days from an amendment to the ethics package, against about 24 in a sponsor's estimate, a median grade of 7.7 from 10.9 in first drafts, and 100% of statements traced. They are targets, to be measured on your own amendments.

Fifteen more consent screens, from the locked statement to the assent form and the rule library

In shortOne amendment is the story. These screens show the rest: required wording, a risk beside its brochure passage, the German form and its rules, the whole list of forms, the teenager's assent form, a committee's question, the dashboard, and the settings a study team sets once.

Seven consent agents, three signatures, and the document systems around them

In shortSeven agents do the reading, drafting, tracing, simplifying, checking and carrying. Named people decide every wording change, sign the master, accept each country form and send each package. The solution reads the documents your team already has and sits beside the systems you keep.

From protocol reader to country adapter: what each consent agent may and may not do

The writer decides each change; the monitor, counsel and country managers sign

Four eyes by design: a person who writes a sentence is never the only person who signs for its accuracy. Each agent step and human decision is on the audit trail with the time and the person. These are controls that support your compliance with your quality system and 21 CFR Part 11; no product can be certified against them. Botminds holds a SOC 2 Type II audit and manages information security to ISO 27001. Documents go in: the solution holds no participant data.

A protocol, a brochure and a template in; a traced family of consent forms out

Document management, translation and e-consent systems around a consent form

Built for a portfolio: three studies on these screens, the same template, rules and targets across them, and each form's grade, stage and date on one list.

What Lena, Dr. Chen, Omar, Priya and Sam want from a consent form

What consent amendments done by hand cost you in writer days, committee rounds and version risk

In shortStart from your own costs. We found no published cost per consent form, error rate or committee query rate, so the numbers that matter are yours. A few published figures frame them: how often protocols change, what a day of a trial costs, and how often inspectors write something up.

Timing one protocol amendment to find your own consent baseline

What no calculator counts: a volunteer misled, a sentence quoted back, a re-consent that slips

What faster consent amendments return when you count writer hours and committee questions

In shortPut in your own numbers. No published figure supplies these inputs, so every default below is an assumption to replace. The calculator values the hours saved across forms and the rework from committee questions, then sets them against what the tool and your testing cost a year. It leaves out what matters most, fewer wrong sentences and earlier approvals, because those have no honest dollar figure.

Finding, proving, copying: where a consent amendment saves

Work out your return from amendments a year, forms per amendment and hourly cost

A sponsor running two global studies a year, with few amendments, may gain more from one good template, a written rule library and one trained writer than from software, and should say so before buying anything. Amendment count, form count and languages are what change the answer.

How ready your medical writing team is: amendment volume, master template, country rules and sign-off

In shortPick the answer closest to your team today. Eight questions score 0 to 2; the last is for reflection. The meter adds up your score as you go, and each question says why it matters and what a strong answer sounds like.

A low score means writing down your template and country rules first

What to ask an ICF authoring tool or writing vendor about sources, locked wording and tracked changes

In shortAsk every vendor the same questions, us included. The answers show how a form is built: what each sentence rests on, what can never be rewritten, how country forms stay intact, how plainness is measured, who decides, and how you would test it on your own amendment.

We found no published independent comparison of consent authoring vendors, as of November 2026. A planted-error test on a finished amendment is the fairest measure, and it measures your current process too.

Test consent authoring software on a protocol amendment you have already finished

In shortUse a finished amendment, because you already know the answer: which sentences changed, what committees asked and how long it took. Plant a few errors, run the tool blind, then run it in parallel on a live amendment. Decide with four numbers, and keep your people signing throughout.

1. Audit ten approved forms against their protocols and brochures, sentence by sentence, and log each error by type. That is your error baseline.
2. Pick one finished amendment with at least four country versions, a changed number and a changed risk.
3. Plant known errors in a copy and run the tool blind, without telling the vendor where they are: a stale visit count, a rounded-down risk, a missing element, a rewritten required sentence, a change in a country's insurance wording.
4. Run in parallel on a live amendment for eight weeks, with your writers and monitors signing every form.
5. Decide with four numbers: catch rate by error type, false alarms on clean copies, hours per form, and how many key questions real readers can answer from the first page.

Catch rate, false alarms and readers' answers on a consent pilot

What people ask about informed consent forms, reading level, re-consent and AI drafting

In shortQuestions people search about consent form authoring, each answered on its own.